Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories

被引：13

作者：

Freydiere, AM

Perry, JD

Faure, O

Willinger, B

Tortorano, AM

Nicholson, A

Peman, J

Verweij, PE

机构：

[1] Hop Debrousse, Hosp Civils Lyon, Bacteriol Lab, F-69322 Lyon 05, France

[2] Ctr Hosp Univ, Grenoble, France

[3] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England

[4] Med Univ Vienna, Div Clin Microbiol, Inst Med Microbiol & Hyg, Vienna, Austria

[5] Univ Milan, Milan, Italy

[6] Univ Valencia, Hosp La Fe, Valencia, Spain

[7] Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2004年 / 42卷 / 10期

关键词：

D O I：

10.1128/JCM.42.10.4870-4872.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.

引用

页码：4870 / 4872

页数：3